Professor
Department of Pathology and Molecular Medicine, Queen's University
Kingston, Ontario, Canada
David Lillicrap is a Professor in the Department of Pathology and Molecular Medicine at Queen’s University, Kingston, Canada. He is the recipient of a Senior Canada Research Chair in Molecular Hemostasis. In 2013, he was elected to the Fellowship of the Royal Society of Canada. Dr Lillicrap is a past member of the World Federation of Hemophilia’s (WFH) Medical Advisory Board and a past Chair of the WFH’s Research Committee. He is a past Chairman of the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee and member of the Council of ISTH. Between 2008–2014 he served as an Associate Editor of Blood and is currently Co Editor in-Chief of the Journal of Thrombosis and Haemostasis.
Dr Lillicrap’s research interests are centered on molecular aspects of the haemostatic system, with a particular emphasis on the potential of molecular genetics and molecular biology to address questions relating to pathological haemostasis. The main foci of interest of his research group are the investigation of the immune response to factor VIII (FVIII), the development and evaluation of novel therapies for haemophilia A, and characterisation of the biology and pathobiology of von Willebrand factor.
Saturday, June 24, 2023
11:15 – 11:30 ET
PL 02.2 - Alan Giles Memorial Lecture
Sunday, June 25, 2023
09:30 – 10:15 ET
OC 13.1 - Scavenger Receptor Stabilin-2 is a Major Regulator of VWF Propeptide Clearance
Sunday, June 25, 2023
10:45 – 11:00 ET
Sunday, June 25, 2023
11:45 – 12:00 ET
PB0153 - Evaluation of cell type-specificity of native enhancer elements from the F8 locus
Sunday, June 25, 2023
18:30 – 19:30 ET
PB0246 - FXIII Deficiency: A genetic diagnostic dilemma
Sunday, June 25, 2023
18:30 – 19:30 ET
OC 30.6 - Hemophilia Gene Therapy Basic Science
Monday, June 26, 2023
10:45 – 12:00 ET
PB0604 - The VWF-ADAMTS13 axis as biomarkers of disease progression in severe COVID-19
Monday, June 26, 2023
18:30 – 19:30 ET
Monday, June 26, 2023
18:30 – 19:30 ET
PB0815 - Involvement of the nuclear protein, TC2N, in regulating VWF levels in endothelial cells
Monday, June 26, 2023
18:30 – 19:30 ET
SOA 25.1 - Hemophilia A: Inhibitor Prevention and Eradication in 2023 and Beyond
Wednesday, June 28, 2023
08:30 – 08:55 ET